Prof Haryana Dhillon

@hagsie.bsky.social

10 months ago

Great start to the week with participant #93 (of planned 100) randomised to #OXTOX trial investigating treatments for #CIPN in people with #CRCSM receiving #Oxali #Chemo #OzOnc #SuppOnc #bowelcancer